Implications of microRNA dysregulation in the development of prostate cancer

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression post-transcriptionally.
• miRNAs are implicated in numerous biological pathways and cellular processes.
• Dysregulation of miRNAs contributes to the initiation and progression of various diseases, including prostate cancer (PCa).

Purpose of the Study:

• To review the current understanding of miRNA involvement in prostate cancer (PCa).
• To summarize the roles of specific miRNAs in PCa initiation, progression, and hallmarks.
• To discuss the potential of miRNAs as diagnostic biomarkers and therapeutic targets in PCa.

Main Methods:

• Literature review of recent research on miRNAs in PCa.
• Analysis of miRNA roles in PCa-associated biological pathways (androgen pathway, proliferation, cell cycle, apoptosis, invasion, metastasis).
• Examination of circulating miRNAs for PCa patient stratification and miRNA-based therapeutic strategies.

Main Results:

• miRNAs significantly influence key cancer hallmarks such as proliferation, cell cycle control, apoptosis, and metastasis in PCa.
• Specific miRNAs are associated with different stages of PCa initiation and progression.
• Circulating miRNAs show promise for non-invasive PCa detection and patient stratification.
• miRNAs represent viable targets for novel PCa therapies, with ongoing research into miRNA delivery systems.

Conclusions:

• miRNAs are critical players in prostate cancer biology, affecting multiple cellular processes.
• miRNAs hold significant potential for improving PCa diagnostics, prognostics, and treatment strategies.
• Further research into miRNA mechanisms and delivery is essential for clinical translation in PCa therapy.